Abstract:Background: Amyloid-β deposition and accumulation of autophagic vacuoles are pathologic features of Alzheimer's disease (AD). Dysregulation of the endosomal–autophagic–lysosomal (EAL) pathway, which impairs amyloid precursor protein processing, is one of the earliest changes in AD. However, the precise role of EAL pathway in neurodegeneration remains unclear. This study aimed to investigate the role of EAL pathway in AD and further study the mechanism of EAL dysfunction. Methods: We used 3-, 7-, and 12-month-old APPswe/PSEN1dE9 (APP/PS1) mice to model different stages of AD with age- and gender-matched wild-type littermates as controls (4–7 mice per group) and detected the changes of EAL markers, endosomal organizers Rab5 and Rab7, autophagosome marker LC3B, and lysosomal proteins Lamp1/2 in cortex and hippocampus by immunohistochemistry and Western blotting analysis. To further explore the mechanism of EAL dysregulation in AD, components of the class III phosphatidylinositol 3-kinase (PI3KC3) complex, activators of Rab7 (Beclin1 and UVRAG), and the negative regulator of Rab7 (Rubicon) were also measured in this two brain regions. Results: In 7-month-old APP/PS1 brain that amyloid beta initiated to accumulate intracellularly, EAL pathway, and related PI3KC3 members, UVRAG and Beclin1 were upregulated both in cortex and hippocampus (all P < 0.05). By the age of 12 months old, when abundant amyloid plaques formed, EAL markers, UVRAG, and Beclin1 were also upregulated in the cortex (all P < 0.05). However, Rab7 was decreased significantly (P = 0.0447), accompanied by a reduction of its activating PI3KC complex component Beclin1 (P = 0.0215) and enhancement of its inhibiting component Rubicon (P = 0.0055) in the hippocampus. Conclusions: Our study implies that EAL pathway, represented as Rab7 and its PI3KC3 regulators' expressions, showed temporal and spatial variation in brains at different stages of AD. It provides new insights into the role of EAL pathway in pathogenesis and indicates potential therapeutic targets in neurodegenerative diseases.

Oncogene K-Ras Affects the Processing of Amyloid Precursor Protein (APP) Through Regulating Its Phosphorylation at Thr668

New Protein Kinase C Activator Regulates Amyloid Precursor Protein Processing In Vitro By Increasing Alpha-Secretase Activity

New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α-secretase activity: New PKC activator increases α-secretase activity

App Regulates Ngf Receptor Trafficking And Ngf-Mediated Neuronal Differentiation And Survival

Receptor Tyrosine Kinases Positively Regulate BACE Activity and Amyloid-β Production Through Enhancing BACE Internalization

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Rho‐associated Coiled‐coil Kinase 1 Activation Mediates Amyloid Precursor Protein Site‐specific Ser655 Phosphorylation and Triggers Amyloid Pathology

TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer’s disease pathologies

Lost Region in Amyloid Precursor Protein (APP) Through TALEN-mediated Genome Editing Alters Mitochondrial Morphology.

Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease

Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes

Involvement Of Receptor Tyrosine Kinase Tyro3 In Amyloidogenic App Processing And Beta-Amyloid Deposition In Alzheimer'S Disease Models

Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.

Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7

Regulation of Neurotransmitter Release by Amyloid Precursor Protein Through Synapsin Phosphorylation

Regulation of Α2a Adrenergic Receptor Trafficking and Signaling by Amyloid Precursor Protein

The Neuroprotection of KIBRA in Promoting Neuron Survival and Against Amyloid β-Induced Apoptosis

P4‐188: MAPKS SIGNALING PATHWAYS REGULATES THE ACTIVATION OF LRP1 RECEPTOR ON THE INTERNALIZATION OF Aβ <sub>1‐42</sub> AND Aβ <sub>1‐42</sub> ‐INDUCED NEUROTOXICITY

Delta-secretase Cleaves Amyloid Precursor Protein and Regulates the Pathogenesis in Alzheimer's Disease

Inhibition of Autophagy Alters Intracellular Transport of APP Resulting in Increased APP Processing

Distinct Rab7-related Endosomal–Autophagic–Lysosomal Dysregulation Observed in Cortex and Hippocampus in APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease